Pharmaceutical Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X

Most Read

  1. Atea closes $215m Series D round to support Covid-19 trials
  2. PTC acquires Censa: diversifying into metabolic disease
  3. Rapid Micro Biosystems raises $120m: improving contamination testing in pharma
  4. Beyond M&As: will 2020 by the year of the spin-out?
  5. Vertex-Affinia partnership: expanding the gene therapy toolkit

Company A-Z

Latest Content

Covid-19 pandemic: overcoming big pharma’s infectious disease market failure

Infectious diseases have been largely pushed to the wayside by big pharma because they are unable to bring the same profits as other conditions, such as cancer and chronic diseases. Octopus Ventures’ Uzma Choudry explains the reasons behind the failure and why she is hopeful the current Covid-19 pandemic will change attitudes towards the serious public health threats infectious diseases cause.

Latest News

Read our magazine

Pharma Technology Focus is the essential reading material for decision-makers in the pharmaceutical industry, bringing you the latest news and analysis in an exciting, interactive format.

Send me notifications of new editions:

Close
Close
Close

Go Top